TML-6

DRUG2 trials

Sponsors

Merry Life Biomedical Co. Ltd., Merry Life Biomedical Co., Ltd.

Conditions

Alzheimer DiseaseEarly Alzheimer’s Disease

Phase 2

A Study to Evaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's Disease

Not yet recruitingNCT07612150

Merry Life Biomedical Co., Ltd.Alzheimer Disease

Start: 2026-08-01End: 2028-07-31Target: 210Updated: 2026-05-28

An Exploratory Phase 2 Multicenter, Double-blind, Randomized, Placebo controlled, Parallel Group Study to Investigate the Safety, Tolerability, and Efficacy of TML-6 in Early Alzheimer’s Disease

Not yet recruitingCTIS2026-525539-18-00

Merry Life Biomedical Co. Ltd.Early Alzheimer’s Disease

Target: 70Updated: 2026-08-14